Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.54 USD | -1.88% | -5.50% | -18.76% |
06:31pm | Bristol-Myers Squibb Unveils Positive Data for KarXT in Schizophrenia Treatment | MT |
05-22 | Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.76% | 85.83B | |
+37.97% | 723B | |
+34.28% | 595B | |
-4.50% | 369B | |
+20.09% | 332B | |
+2.74% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.03% | 168B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Bristol Myers Squibb : Opdivo Meets Phase 3 Lung Cancer Study Goals